Article

Utjecaj kompleksacije piroksikama s ciklodekstrinima na oblikovanje gela

Acta pharmaceutica (hfd-fg-ap@zg.htnet.hr); Vol.55 No.3 DOI:http://hrcak.srce.hr/file/25814
Source: OAI

ABSTRACT The aim of this work was to evaluate the role of cyclodextrins in topical drug formulations. Solid piroxicam (PX) complexes with beta-cyclodextrin (beta-CD) and randomly methylated beta-cyclodextrin (RAMEB) were prepared by freeze-drying and characterized using differential scanning calorimetry (DSC), X-ray powder diffractometry (XRPD), Fourier transform infrared spectroscopy (FTIR) and near infrared spectroscopy (NIR). A physical mixture of PX and cyclodextrins was characterized by enhanced dissolution properties compared to the dissolution profile of the pure drug due to in situ complex formation. Formation of the PX-cyclodextrin inclusion complex additionally improved the drug dissolution properties. Influence of CDs on drug permeation from the water dispersion and the prepared hydroxypropyl methylcellulose (HPMC) gels was investigated. Permeation of the drug involved three consecutive processes: dissolution of the solid phase, diffusion across the swollen polymer matrix and drug permeation through the membrane. Complexation increased PX diffusion by increasing the amount of diffusible species in the donor phase. Slower drug diffusion through the HPMC matrix was the rate limiting step in the overall diffusion process. Possible interaction between the hydrophilic polymer and cyclodextrin may result in physicochemical changes, especially in a change of rheological parameters.

0 0
 · 
0 Bookmarks
 · 
32 Views

Keywords

diffusible species
 
dissolution profile
 
donor phase
 
drug dissolution properties
 
hydrophilic polymer
 
infrared spectroscopy
 
physicochemical changes
 
Possible interaction
 
prepared hydroxypropyl methylcellulose
 
pure drug
 
PX diffusion
 
PX-cyclodextrin inclusion complex additionally
 
randomly methylated beta-cyclodextrin
 
rheological parameters
 
situ complex formation
 
Slower drug diffusion
 
solid phase
 
Solid piroxicam
 
swollen polymer matrix
 
topical drug formulations